Parmley WW.  Pathophysiology and current therapy of congestive heart failure. J Am Coll Cardiol . 1989;;13:771-785.
Stauffer JC, Gaasch WH.  Recognition and treatment of left ventricular diastolic dysfunction. Prog Cardiovasc Dis . 1990;;32:319-332.
McKee PA, Castelli WP, McNamara PM, Kannel WB.  The natural history of congestive heart failure: the Framingham Study. N Engl J Med . 1971;; 285:1441-1446.
Harlan WR, Oberman A, Grimm R, Rosati RA.  Chronic congestive heart failure in coronary artery disease: clinical criteria. Ann Intern Med . 1977;;86: 133-138.
Carlson KJ, Lee DCS, Goroll AH, Leahy M, Johnson RA.  An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients. J Chronic Dis . 1985;;38:733-739.
Marantz PR, Tobin JN, Wassertheil-Smoller S, et al.  The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation . 1988;;77:607-612.
Echeverria HH, Bilisker MS, Myerburg RJ, Kessler KM.  Congestive heart failure: echocardiographic insights. Am J Med . 1983;;75:750-755.
Ghali JK, Kadakia S, Cooper RS, Liao Y.  Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failure. Am J Cardiol . 1991;;67:1002-1006.
Grossman W.  Diastolic dysfunction in congestive heart failure. N Engl J Med . 1991;;325:1557-1564.
Bonow RO, Udelson JE.  Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management. Ann Intern Med . 1992;;117:502-510.
Gaasch WH, Blaustein AS, LeWinter MM.  Heart failure and clinical disorders of left ventricular diastolic function. In: Gaasch WH, LeWinter MM, eds. Left Ventricular Diastolic Dysfunction and Heart Failure . Philadelphia, Pa: Lea & Febiger; 1994;.
Levine HJ, Gaasch WH.  Clinical recognition and treatment of diastolic dysfunction and heart failure. In: Gaasch WH, LeWinter MM, eds. Left Ventricular Diastolic Dysfunction and Heart Failure . Philadelphia, Pa: Lea & Febiger; 1994;.
Johnson RA, Palacios I.  Dilated cardiomyopathies of the adult. N Engl J Med . 1982;;307:1051-1058.
Force TL, Folland ED, Aebischer N, Sharma S, Parisi AF.  Echocardiographic assessment of ventricular function. In: Marcus ML, Schelbert HR, Skorton DJ, Wolf JL, eds. Cardiac Imaging . Philadelphia, Pa: WB Saunders Co; 1991;.
Amico AF, Lichtenberg GS, Reisner SA, Stone CK, Schwartz RG, Meltzer RS.  Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction. Am Heart J . 1989;;118:1259-1265.
Cohn JN, Archibald DG, Ziesche S, et al.  Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med . 1986;; 314:1547-1552.
Massie BM, Conway M.  Survival of patients with congestive heart failure: past, present and future prospects. Circulation . 1987;;75(
(suppl 4)
):11-19.
The CONSENSUS Trial Study Group.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med . 1987;;316:1729-1735.
The SOLVD Investigators.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med . 1991;;325:293-302.
Cohn JN, Johnson G, Ziesche S, et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med . 1991;;325:303-310.
The SOLVD Investigators.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med . 1992;;327: 685-691.
Pfeffer MA, Braunwald E, Moye LA, et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med . 1992;; 327:669-677.
Swedberg K, Held P, Kjekshus J, et al.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med . 1992;;327:678-684.
Carroll JD, Hess OM, Hirzel HO, et al.  Left ventricular systolic and diastolic function in coronary artery disease: effects of revascularization on exercise-induced ischemia. Circulation . 1985;;72:119-129.
Cuocolo A, Sax FL, Brush JE, et al.  Left ventricular hypertrophy and impaired diastolic filling in essential hypertension: diastolic mechanisms for systolic dysfunction during exercise. Circulation . 1990;;81:978-986.
Clyne CA, Arrighi JA, Maron BJ, et al.  Systemic and left ventricular response to exercise stress in asymptomatic patients with valvular aortic stenosis. Am J Cardiol . 1991;;68:1469-1476.
Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ.  Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol . 1991;;17:1065-1072.
Chon JN, Johnson G.  Heart failure with normal ejection fraction: the V-HeFT study. Circulation . 1990;;81:48-53.
Setaro JF, Soufer R, Remetz MS, Perlmutter RA, Zaret BL.  Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol . 1992;;69:1212-1216.
Judge KW, Pawitan Y, Caldwell J, et al.  Congestive heart failure in patients with preserved left ventricular systolic function: analysis of the CASS registry. J Am Coll Cardiol . 1991;;18:377-382.
Brogan WC, Hillis LD, Flores ED, et al.  The natural history of isolated left ventricular diastolic dysfunction. Am J Med . 1992;;92:627-630.
Dougherty AH, Naccarelli GV, Grey EL, et al.  Congestive heart failure with normal systolic function. Am J Cardiol . 1984;;54:778-782.
Soufer R, Wohlgelernter D, Vita NA, et al.  Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol . 1985;;55: 1032-1036.
Forman DE, Coletta D, Kenny D, et al.  Clinical issues related to discontinuing digoxin therapy in elderly nursing home patients. Arch Intern Med . 1991;;151:2194-2198.
Topol EJ, Traill TA, Fortuin NJ.  Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med . 1985;;312:277-283.
Bonow RO, Dilsizian V, Rosing DR, et al.  Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short and long-term effects. Circulation . 1985;;75:853-864.
Setaro JF, Zaret BL, Schulman DS, et al.  Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol . 1990;;66:981-986.
Given BD, Lee TH, Stone PH, Dzau VJ.  Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function. Arch Intern Med . 1985;;145:281-285.
Lorell BH, Isoyama S, Grice WN, et al.  Effects of ouabain and isoproterenol on left ventricular diastolic function during low-flow ischemia in isolated, blood perfused rabbit hearts. Circ Res . 1988;; 63:457-467.
Schunkert H, Dzau VJ, Tang SS, et al.  Increased rat cardiac angiotensin converting emzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest . 1990;;86:1913-1920.
Koren MJ, Devereux RB, Casale PN, et al.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med . 1991;;114:345-352.
Shimizu G, Hirota Y, Kita Y, et al.  Left ventricular midwall mechanics in systemic arterial hypertension: myocardial function is depressed in pressure-overload hypertrophy. Circulation . 1991;;83: 1676-1684.
Lorell BH, Grossman W.  Cardiac hypertrophy: the consequences for diastole. J Am Coll Cardiol . 1987;;9:1189-1193.
Hoit BD, Walsh RA.  Diastolic dysfunction in hypertensive heart disease. In: Gaasch WH, LeWinter MM, eds. Left Ventricular Diastolic Dysfunction and Heart Failure . Philadelphia, Pa: Lea & Febiger; 1994;.
Hammond IW, Devereux RB, Alderman MH, et al.  The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol . 1986;;7:639-650.
Savage DD, Garrison RJ, Kannel WB, et al.  The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation . 1987;;75:26-33.
Savage DD, Drayer JI, Henry WL, et al.  Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation . 1979;;59:623-632.
Cutler JA, MacMahon SW, Furberg CD.  Controlled clinical trials of drug treatment for hypertension: a review. Hypertension . 1989;;13:1-36.
Frohlich ED, Apstein CS, Chobanian AV, et al.  The heart in hypertension. N Engl J Med . 1992;; 327:996-1008.
Dahlof B, Pennert K, Hansson L.  Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertension . 1992;;5:95-110.